美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MEDP近 30 天 14 則 · 第 1 / 1 頁
- 1 Volatile Stock with Solid Fundamentals and 2 Facing Challenges
- Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
- CON vs. MEDP: Which Stock Is the Better Value Option?
- 2 Healthcare Stocks with Competitive Advantages and 1 We Question
- Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
- Innventure Announces Board Leadership Changes to Further Enhance Board Independence and Acceleration of CEO Transition
- Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound?
- Medpace (MEDP): Buy, Sell, or Hold Post Q2 Earnings?
- Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike
- CON vs. MEDP: Which Stock Should Value Investors Buy Now?
- What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
- Can AI Innovation and CRM Wins Boost Veeva Systems' Q2 Results?
- Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?
- CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?
- Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
- Medpace (MEDP) Stock May Be 9% Undervalued As Growth Expectations Hold
- Will Medpace’s (MEDP) Revenue Beat and Guidance Hike Change Medpace Holdings' (MEDP) Narrative
- Medpace Holdings (MEDP) Following Its Q2 Beat And Guidance Raise Looks Fully Valued
- Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
- 2 Mid-Cap Stocks Worth Your Attention and 1 We Question
- This Healthcare Services Stock Has 37% Upside
- Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。